Converge Bio August 2025 a Series of CGF2021 LLC
Claymont, De
Converge Bio August 2025 a Series of CGF2021 LLC is a venture capital fund managed by Converge Bio August 2025 A Series Of Cgf2021 LLC. Its SEC Form D filing reports $154,500 raised, a $154,500 target, 2 investors, and a first sale on October 23, 2025.
Amount Raised
$154,500
Target Size
$154,500
Investors
2
Date Filed
2025-10-29
Dry powder breakdown
Est. Remaining
$119,094
Deployed
$35,406
23% deployed37 months remaining (4yr model)
Raised 100% of $154,500 target
Filing details
Fund vehicleConverge Bio August 2025 a Series of CGF2021 LLC
IndustryVenture Capital Fund
Address2093 PHILADELPHIA PIKE, CLAYMONT, DE
Phone(360) 946-0604
Accession #0002093934-25-000001
Related personsView on SEC EDGAR ↗